Your landing page’s weakest score is Trust.
How Recursion ranks
Trust
58FairProof that the product is real, competent, and safe to try.


| Trust read | |
|---|---|
| Recursion | Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration |
| "Backed by — YCombinator" table row | |
| Pipeline table rows showing "Out-licensed to Exelixis" and "Out-licensed to Menarini" with Phase I–III progress bars and | |
| Photograph of a clinician consulting with a hospital patient behind the hero headline | |
| No visible trust signal identified. | |
| No visible trust signal identified. |
Mobile web
62FairThe phone experience as a first-class citizen.
123- Six-line hero headline — Desktop-scale type wraps into six huge lines, shoving the CTA to the fold's bottom edge.
- Ghost CTA button — "Explore our Platform" is a thin outline that disappears into the gradient instead of a solid full-width tap target.
- Read more banner — Secondary Genentech announcement with its own button competes for the tap right below the hero.
CTA
68FairCopy, size, verb, cost-feel — does the primary CTA earn the click?

How Recursion compares
Recommended rewrites
Value props
68FairTitle, subtitle, hero — do they sell the product's true value?
The AI engine uncovering novel medicines that matter
Faster, better, and at scale for patients who are waiting
Working
Could improve
Information hierarchy
76FairDoes the design help or inhibit what the page is trying to say?

What works
What to improve
